Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Pfizer defends Covid-19 vaccine effectiveness after Trump remarks

Newsdesk profile image
by Newsdesk
Pfizer defends Covid-19 vaccine effectiveness after Trump remarks

Sign up now: Get ST's newsletters delivered to your inbox Pfizer pointed to a dedicated section on its website where clinical trial findings and safety updates are posted. NEW YORK - Pfizer on Sept 3 defended the effectiveness of its Covid-19 vaccine, saying it has saved more than 14 million lives worldwide, after US President Donald Trump urged pharmaceutical companies to justify the success of their pandemic drugs. In a post on Truth Social, Mr Trump asserted that he has seen “extraordinary” data from companies such as Pfizer, but criticised them for withholding results from the public and the Centres for Disease Control and Prevention. Pfizer’s announcement comes after major upheaval at the CDC last week, as director Susan Monarez was fired after resisting changes to vaccine policy that were advanced by Health Secretary Robert F. Kennedy Jr, who was handpicked by Mr Trump earlier in 2025. Pfizer chief Albert Bourla praised Operation Warp Speed as a “profound public health achievement” under Mr Trump’s leadership, crediting it with saving more than 14 million lives globally and averting over US$1 trillion (S$1.29 trillion) in healthcare costs. Mr Bourla added that such an accomplishment would “typically be worthy of the Nobel Peace Prize”. The drugmaker also welcomed Mr Trump’s demand for openness and pointed to a dedicated section on its website where clinical trial findings and safety updates are posted, adding that new information on its latest vaccine strain, recently cleared by the US Food and Drug Administration, will be published in the coming days. REUTERS


Source: The Straits Times

Newsdesk profile image
by Newsdesk

Be informed!

Rx.news delivers critical healthcare intelligence to pharmaceutical professionals, biotech innovators, healthcare investors, medical practitioners, and policy makers.

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Read More